A detailed history of Vestmark Advisory Solutions, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 200,202 shares of VCYT stock, worth $4.26 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
200,202
Previous 176,315 13.55%
Holding current value
$4.26 Million
Previous $4.85 Million 8.54%
% of portfolio
0.21%
Previous 0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$21.0 - $29.1 $501,627 - $695,111
23,887 Added 13.55%
200,202 $4.44 Million
Q4 2023

Feb 06, 2024

BUY
$19.72 - $28.68 $3.48 Million - $5.06 Million
176,315 New
176,315 $4.85 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $1.52B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.